General
Peptide: | Lasio-III |
Microorganism: | Escherichia coli ATCC 8739 |
Administration: | |
Stage: | Formation (3-24h) |
Notes: |
Experimental procedure
Method | AMP Effect(Biofilm reduction) | Concentration | Notes |
---|---|---|---|
Crystal violet assay | > 90% | 3.5 uM | |
Crystal violet assay | 21 - 50% | 0.875 uM | |
Crystal violet assay | <= 20 % | 0.43 uM | |
OD600 | 21 - 50% | 3.5 uM | |
OD600 | <= 20 % | 0.875 uM |
Reference
- Biswajit Mishra, Anindya Basu, Rathi Saravanan, Li Xiang, Lim Kai Yang, Susanna Su Jan Leong Lasioglossin-III: antimicrobial characterization and feasibility study for immobilization applications
M. Di Luca, G. Maccari, G. Maisetta, G. Batoni BaAMPs: the database of biofilm-active antimicrobial peptides Biofouling 2015; 31(2):193-9.
Please do not hesitate to address comments or questions to: mariagrazia.diluca@nano.cnr.it or gpmaccari@gmail.com